GE HealthCare Techs Q2 Adjusted EPS $0.92 Beats $0.87 Estimate, Sales $4.82B Beat $4.79B Estimate
Portfolio Pulse from Benzinga Newsdesk
GE HealthCare Techs (NASDAQ:GEHC) reported Q2 earnings of $0.92 per share, beating the analyst consensus estimate of $0.87 by 5.75%. However, this is a 20% decrease from the same period last year. The company also reported quarterly sales of $4.82 billion, beating the estimate of $4.79 billion by 0.56%, and marking a 7.43% increase from the same period last year.
July 25, 2023 | 10:22 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GE HealthCare Techs reported better than expected Q2 earnings and sales. However, earnings per share decreased by 20% compared to the same period last year.
While GE HealthCare Techs beat the Q2 earnings and sales estimates, the 20% YoY decrease in earnings per share might concern investors. This mixed result could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100